logo

Akero Therapeutics Inc. (AKRO)



Trade AKRO now with
  Date
  Headline
3/31/2020 6:02:24 AM Akero Therapeutics Says All Three AKR-001 Dose Groups In The BALANCED Study Meets Primary Endpoint
3/16/2020 7:36:59 AM Akero Therapeutics Q4 Net Loss $15.6 Mln Or $0.55/shr Vs. Net Loss $61.7 Mln Or $449.5/shr Last Year
1/13/2020 8:16:59 AM Akero Therapeutics Expands Phase 2a Trial In NASH To Include Cohort Of Cirrhotic Patients
11/12/2019 7:11:38 AM Akero Therapeutics Q3 Loss Per Share $0.56 Vs Loss $89.66 Last Year
6/19/2019 9:33:12 PM Akero Therapeutics Prices IPO Of 5.75 Mln Shares At $16.00/shr
6/15/2019 12:43:04 AM Biotech IPOs For The Week Ahead
  
 
>